The potential for dose escalation in lung cancer as a result of systematically reducing margins used to generate planning target volume

Conclusions: Reduced margins allowed an increased dose to the tumors. However, a much larger dose escalation was possible for some patients but not for others, demonstrating that each patient is different, so individual treatment plans must be tailored for maximum tumor coverage and minimum exposure of healthy tissue.